Montelukast

• Background :

  Montelukast is a cysteinyl leukotriene receptor 1 (CysLT1) antagonist. It blocks pentylenetetrazole-induced seizures, blood brain barrier disruption and leukocyte migration in mice.

• Description :

  Leukotriene CysLT1 antagonist

• CAS Number :

  151767-02-1

• Product Name Alternative :

  1-[[[ (1R) -1-[3- (1E) -2- (7-chloro-2-quinolinyl) ethenyl]phenyl]-3-[2- (1-hydroxy-1-methylethyl) phenyl]propyl]thio]-methyl]-cyclopropaneacetic acid, monosodium salt, Montelukast sodium, Montelukast monosodium salt, MK-0476, MK-476, KS-1087

• UNSPSC :

  41116105

• Type :

  Antagonist

• Source :

  Synthetic

• Field of Research :

  Immunology | Innate Immunity | Macrophage

• Purity :

  >98% (HPLC) ; NMR (Conforms)

• Weight :

  0.25

• Format :

  Powder

• Solubility :

  Soluble in DMSO (50 mg/ml), or water (30 mg/ml), or ethanol (60 mg/ml)

• Molecular Formula :

  C35H35ClNO3S • Na

• Molecular Weight :

  608.2

• Precautions :

  Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.